- Home
- Science
- Life Sciences
- Novel cancer-related biomarkers
Novel cancer-related biomarkers
List Price:
$28.00
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Viktor Magdolen, Christian P. Sommerhoff, Hans Fritz, Manfred Schmitt
Format:
Paperback
Pages:
241
Publisher:
De Gruyter (June 20, 2016)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9783110481532
ISBN-10:
3110481537
Weight:
20.32oz
Dimensions:
6.69" x 9.45"
File:
TWO RIVERS-PERSEUS-Metadata_Only_Perseus_Distribution_Customer_Group_Metadata_20260510163322-20260511.xml
Folder:
TWO RIVERS
List Price:
$28.00
Country of Origin:
Germany
As low as:
$24.08
Publisher Identifier:
P-PER
Discount Code:
C
Pub Discount:
60
Imprint:
De Gruyter
Overview
Various KLK proteins and their encoding genes have attracted increased attention among scientists and clinicians worldwide since they represent very interesting and functionally distinct biomarkers, particularly, in cancer. This book reviews the role of kallikrein-related peptidases (KLKs) in a wide range of cancers, including lung, prostate, breast and ovarian cancer. It provides clinicians, physician scientists and researchers with a comprehensive overview on the clinical relevance of KLK expression in various malignancies.
